Additionally, altering the phosphorylation of p62 enhances the p62-Keap1-Nrf2 positive feedback loop, activating antioxidant defenses to mitigate oxidative damage in neurodegenerative diseases [95]. Here, SQSTM1 is linked to neurodegenerative disease.